Literature DB >> 9292327

Relationship between rate-corrected QT interval and wall motion abnormalities in the setting of acute myocardial infarction.

D Raev1.   

Abstract

We studied 108 patients (73 men and 35 women, mean age of 63.1 +/- 11.2 years) with Q-wave acute myocardial infarction (anterior -52, inferior -41, and combined anteroinferior -15) 4 days after infarct onset to determine whether any correlation exists between rate-corrected QT interval (QTc) and functional infarct size, expressed as wall motion index. QTc was calculated by Hodges' linear algorithm [QT + (1.75 x heart rate - 60)]. Wall motion index was determined using a 16-segments model, as recommended by the American Society of Echocardiography. Wall motion index was significantly higher in anterior and in combined infarctions. QTc was shortest in inferior infarction. There was a statistically significant overall correlation between wall motion index and QTc (r = 0.83, p < 0.001). The relationship was weakest in inferior infarction. In conclusion, prolonged QTc may be implicated as an additional marker of left ventricular dysfunction in patients with acute anterior and combined anteroinferior myocardial infarction.

Entities:  

Mesh:

Year:  1997        PMID: 9292327     DOI: 10.1016/s0167-5273(97)00112-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  2 in total

1.  Prevalence and prognostic significance of long QT interval among patients with chest pain: selecting an optimum QT rate correction formula.

Authors:  Amer A Hasanien; Barbara J Drew; Jill Howie-Esquivel; Gordon Fung; Patricia Harris
Journal:  J Electrocardiol       Date:  2013-04-15       Impact factor: 1.438

2.  Diagnostic flowchart to estimate the morphology of left descending artery lesions by initial electrocardiogram in ST-elevation myocardial infarction.

Authors:  Toshiharu Fujii; Misaki Hasegawa; Norihito Nakamura; Yuji Ikari
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-09-25       Impact factor: 1.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.